SABBY MANAGEMENT, LLC

Position in BCTX — BriaCell Therapeutics Corp.

CIK 1535610 MIAMI BEACH, FL

Position in BCTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$261,536

-$48,167 QoQ

Shares Held

391,906

-40.7% QoQ

Ownership

4.50%

of shares outstanding

% of Portfolio

2.26%

of 13F equity value

Holder Rank

of 18 holders

Holding Since

Mar 2024

6 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

SABBY MANAGEMENT, LLC holds $1,817,490 across 4 Biotechnology names. BCTX ranks #3 (14.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRVO	CervoMed Inc.	248,880	$771,528
2	TPST	Tempest Therapeutics, Inc.	511,286	$567,527
3	BCTX	BriaCell Therapeutics Corp. This page	391,906	$261,536
4	REVB	Revelation Biosciences, Inc.	210,582	$216,899

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30 BCTXL	—	190,383	-50.0%	Shares	Defined	2026-08-14
2026-06-30 BCTXZ	—	120,802	-41.6%	Shares	Defined	2026-08-14
2026-06-30	$261,536	80,721	+9.2%	Shares	Defined	2026-08-14
2026-03-31 BCTXL	—	380,686	—	Shares	Defined	2026-05-15
2026-03-31 BCTXZ	—	206,753	-22.3%	Shares	Defined	2026-05-15
2026-03-31	$309,703	73,915	+87.0%	Shares	Defined	2026-05-15
2025-12-31 BCTXZ	—	265,964	-29.0%	Shares	Defined	2026-02-17
2025-09-30 BCTXZ	—	374,488	-37.5%	Shares	Defined	2025-11-14
2025-06-30 BCTXZ	—	598,743	—	Shares	Defined	2025-08-14
2025-06-30	$116,218	39,530	+15.5%	Shares	Defined	2025-08-14
2024-03-31	$97,874	34,222	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.